Nancy E Davidson
Overview
Explore the profile of Nancy E Davidson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
276
Citations
17814
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hunter N, Peterson L, Specht J, Mankoff D, Muzi M, Chen D, et al.
Breast Cancer Res
. 2025 Feb;
27(1):23.
PMID: 39962532
Background: F-Fluorodeoxyglucose (FDG) and F-Fluorestradiol (FES) have been FDA approved for measuring tumor glycolytic activity and estrogen receptor (ER) uptake, respectively, in clinical positron emission tomography (PET) imaging for patients...
2.
Gu T, Vasilatos S, Yin J, Qin Y, Zhang L, Davidson N, et al.
Cancer Lett
. 2024 Aug;
600:217182.
PMID: 39154703
Histone lysine-specific demethylase 1 (LSD1) is frequently overexpressed in triple negative breast cancer (TNBC), which is associated with worse clinical outcome in TNBC patients. However, the underlying mechanisms by which...
3.
ORegan R, Zhang Y, Fleming G, Francis P, Kammler R, Viale G, et al.
JAMA Oncol
. 2024 Aug;
10(10):1379-1389.
PMID: 39145953
Importance: Adjuvant ovarian function suppression (OFS) with oral endocrine therapy improves outcomes for premenopausal patients with hormone receptor-positive (HR+) breast cancer but adds adverse effects. A genomic biomarker for selecting...
4.
Greenlee H, Rillamas-Sun E, Yung R, Cobos S, Donzella S, Huang Y, et al.
NPJ Breast Cancer
. 2024 Jul;
10(1):62.
PMID: 39054321
We tested the feasibility and preliminary efficacy of an online diet and physical activity program for women with early-stage breast cancer who had completed surgery, chemotherapy, and radiation therapy (ongoing...
5.
6.
Wright J, Gray R, Rahbar H, Comstock C, Tjoe J, Badve S, et al.
NPJ Breast Cancer
. 2024 Feb;
10(1):16.
PMID: 38396024
We report the 20-year rate of ipsilateral breast event (IBE) for patients with ductal carcinoma in situ (DCIS) treated with lumpectomy without radiation on a non-randomized prospective clinical trial. Patients...
7.
Yin J, Gu T, Chaudhry N, Davidson N, Huang Y
Front Immunol
. 2024 Jan;
14:1325615.
PMID: 38268926
Breast cancer (BC) is the most common non-skin cancer and the second leading cause of cancer death in American women. The initiation and progression of BC can proceed through the...
8.
Symonds L, Davidson N
J Natl Cancer Inst
. 2023 Jul;
115(11):1240-1242.
PMID: 37480258
No abstract available.
9.
Chen Y, Li H, Janowczyk A, Toro P, Corredor G, Whitney J, et al.
NPJ Breast Cancer
. 2023 May;
9(1):40.
PMID: 37198173
Prognostic markers currently utilized in clinical practice for estrogen receptor-positive (ER+) and lymph node-negative (LN-) invasive breast cancer (IBC) patients include the Nottingham grading system and Oncotype Dx (ODx). However,...
10.
Garcia-Recio S, Hinoue T, Wheeler G, Kelly B, Garrido-Castro A, Pascual T, et al.
Nat Cancer
. 2022 Dec;
4(1):128-147.
PMID: 36585450
The AURORA US Metastasis Project was established with the goal to identify molecular features associated with metastasis. We assayed 55 females with metastatic breast cancer (51 primary cancers and 102...